Details of the Drug Reposition

General Information of This Drug (ID: DM8D13S)

Drug Name
MABp1   DM8D13S

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Colorectal cancer DISNH7P9 2B91.Z Phase 3 [1]
------------------------------------------------------------------------------------
7 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Type-2 diabetes DIS3X247 5A11 Phase 2 [2]
Peripheral vascular disease DISXSU1Y BD4Z Phase 2 [3]
Atopic dermatitis DISTCP41 EA80 Phase 2 [4]
Plaque psoriasis DISQX1LF EA90.0 Phase 2 [4]
Pyoderma gangrenosum DIS8QVTT EB21 Phase 2 [4]
Acne vulgaris DISKW8PI ED80 Phase 2 [4]
Hidradenitis suppurativa DIS3ZNAK ED92.0 Phase 2 [4]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Indications(s)

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)